APPB (Applied Biosciences) Total Operating Expense: $3.21 Mil (TTM As of Dec. 2019)


APPB Applied Biosciences Corp APPB
12 GF Score
Price $0.00
View Full Analysis

What is Applied Biosciences Total Operating Expense?

Applied Biosciences APPB 12 Total Operating Expense is $3.21 Mil as of Dec. 2019. GuruFocus rates APPB with a GF Score™ of 12/100.

Applied Biosciences's Total Operating Expense for the three months ended in Dec. 2019 was $1.09 Mil. Applied Biosciences's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2019 was $3.21 Mil.

Applied Biosciences Total Operating Expense Related Terms

Applied Biosciences Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Applied Biosciences's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied Biosciences Total Operating Expense Chart

Applied Biosciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18
Total Operating Expense
0.00 0.02 0.03 0.18 1.54

Applied Biosciences Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.42 0.56 0.59 0.97 1.09
APPB
12GF Score
Applied Biosciences Corp APPB
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Applied Biosciences Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $3.21 Mil mean?
Applied Biosciences (APPB) has a Total Operating Expense of $3.21 Mil as of Dec. 2019. Total operating expense is the primary recurring expense associated with central operations. View historical data on Applied Biosciences and its competitors.
Is Applied Biosciences' Total Operating Expense too high?
Applied Biosciences' current Total Operating Expense is $3.21 Mil. Overall, Applied Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Applied Biosciences' Total Operating Expense compare to CNABQ and OWCP?
Applied Biosciences' Total Operating Expense of $3.21 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Applied Biosciences and its competitors. Applied Biosciences's current Total Operating Expense is $3.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Applied Biosciences stock overvalued right now?
Applied Biosciences (APPB) has a current Total Operating Expense of $3.21 Mil. The current Total Operating Expense is $3.21 Mil. Applied Biosciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Applied Biosciences (APPB), the current Total Operating Expense is $3.21 Mil as of Dec. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Applied Biosciences Business Description

Address 112 North Curry Street, 18th Floor, Carson, NY, USA, 89703
Applied Biosciences Corp is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics / biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. The company also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to its customers.
12GF Score

Get the complete analysis for APPB

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price